Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Fuzhou Aidikang Medical Laboratory Co., Ltd., established on 2009-02-06, Business scope includes licensed projects:medical service;Import and export;Technology Import and Export;road freight transport(Does not contain dangerous goods)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Sales of Class I Medical Devices;software development;software sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information system integration service;Wholesale of computer software, hardware and auxiliary equipment;Retailing of computer software, hardware and auxiliary equipment;Socioeconomic Advisory Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

Shenzhen Kanghua Juntai Biotechnology Co., Ltd., established on 2020-03-18, Business scope includes general business items:Computer Network Information Service,Biological Technology,Class I medical device,biologics,medical products,Technology development of Chinese herbal medicine,technical consulting,Technical Services,Transfer of self-owned technological achievements;Class I medical device sales;Domestic Trade,Operating import and export business(law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council).(Business operations involving administrative licensing,Must obtain administrative license documents before operating),The licensing program is:

Guangzhou Yongnuo Biotechnology Co., Ltd., established on 2010-12-03, Business scope includes medical equipment rental services;Biotechnology Extension Services;Patent Service;Information Technology Consulting Services;Biotechnology Development Services;General Equipment Repair;Medical Research and Experimental Development;Instrument Repair;Science and Technology Information Consulting Services;drug development;Biotechnology Consulting,communication service;translation service;Medical Equipment Repair;Import and export(Excluding franchised products);Biotechnology Transfer Services;Natural science research and experimental development;Business Management Consulting Services;Commodity retail trade(Except for licensed and approved products);Technology Import and Export;Data Processing and Storage Services;Nutrition and Health Consulting Services;Commodity wholesale trade(Except for licensed and approved products);Research and development of biological products(Does not include licensed operations);Research and development of biodiagnostic reagents and kits(Does not include license approval items);Operation of non-licensed medical devices;Sales of products produced by the company(Except for projects prohibited by national laws and regulations;Products involving licensed operation need to obtain a license before they can be operated);Sales of biological diagnostic reagents and kits(Does not include license approval items);Sales of Biological Products(Does not include licensed operations);Technology intermediary service;Corporate Image Planning Service;medical diagnosis,Monitoring and treatment equipment retail;medical diagnosis,Monitoring and treatment equipment wholesale;Licensed medical device business;

Encore (Chongqing) Biomedical Technology Co., Ltd., established on 2021-02-07, Business scope includes licensed projects:Production of Class II Medical Devices;Class III medical device business;Production of Class III Medical Devices;Cosmetic production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Business Management Consulting;Sales of Class I Medical Devices;Production of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Retail;Cosmetics Wholesale;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);R&D and application of cell technology;Human stem cell technology development and application.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Immucor GTI Diagnostics, Inc., part of Immucor, Inc., is a company headquartered in Waukesha, WI. The firm develops, manufactures and sells transfusion and transplantation diagnostics products.

HTG Molecular Diagnostics is a provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. The Company's NGS-adapted chemistry and HTG EdgeSeq technology automate sample processing and can swiftly, reliably, and concurrently profile hundreds or thousands of molecular targets utilizing a very little quantity of biological material, in liquid or solid form. Its products comprise equipment, consumables, and software that work together to form the HTG EdgeSeq platform. The HTG EdgeSeq platform automates the company's menu of HTG EdgeSeq molecular profiling panels, which use genomic sequencing techniques to swiftly provide gene expression data for clients utilizing its streamlined approach. HTG Molecular Diagnostics was established in 1997 by Bruce E. Seligmann in Tucson, Arizona.